Resource: FDA COVID-19 Updates
Source: U.S. Food and Drug Administration
Summary: In a new “FDA Voices”, entitled the FDA’s Vaccines and Related Biological Products Products Advisory Committee and its Role in Advising the Agency on COVID-19 Vaccines, Peter Marks, MD, PHD, highlights the value of transparency.
Comment: This update emphasizes the FDA’s continued push for transparency in developing the COVID-19 vaccine. In many nationwide polls, there is evidence that less than half of Americans indicate they would receive the COVID-19 vaccine. The push for transparency is the FDA saying they would like as many people to be vaccinated as possible.
